Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
Business Wire•27/10/2026•16:05 ET
0
Key Highlights
- ➤Corcept will report third-quarter financial results and provide a corporate update November 3, 2026
- ➤Conference call scheduled November 3, 2026, at 5:00 p.m. Eastern Time
- ➤Lifyorli introduced in March 2026 for platinum-resistant ovarian cancer
- ➤Lifyorli is the first FDA-approved selective glucocorticoid receptor antagonist
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update on November 3, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
Get started
Create a free account to read the full story.